DrugDashboards

Market view

colistimethate sodium · Powder

16 marketed package NDCs · 3 active manufacturers

Most dispensed: 150 mg · Injection, Powder, For Solution · #12 vial, glass/carton / 1 injection, powder, for solution in 1 vial, glass · 150 mg/2mL · Injection, Powder, Lyophilized, For Solution · #1 vial/box / 2 ml in 1 vial · 150 mg · Injection, Powder, For Solution · #1 vial/carton / 1 injection, powder, for solution in 1 vial · 150 mg · Injection, Powder, For Solution · #1 vial, glass/carton / 1 injection, powder, for solution in 1 vial, glass

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

Same drug class

Other molecules FDA puts in Polymyxin-class Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Colistimethate sodium in shortage right now?
No. FDA does not currently list Colistimethate sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Colistimethate sodium?
8 companies have marketed Colistimethate sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Colistimethate sodium cost?
The typical pharmacy pays about $15.49 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.